Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 38
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Osteoarthritis Cartilage ; 30(8): 1140-1153, 2022 08.
Artículo en Inglés | MEDLINE | ID: mdl-35513247

RESUMEN

OBJECTIVE: This study aimed to explore the effect and mechanism of chondrocyte apoptosis on the chemotaxis of osteoclast precursors (OCPs) during bone destruction. DESIGN: The relationship between cartilage and bone destruction was verified with a rat temporomandibular joint osteoarthritis (TMJOA) model. The pan-caspase inhibitor Z-VAD-FMK (ZVAD) was applied to confirm the chemotactic effect of chondrocyte apoptosis on OCPs. Synthesis and release of the key chemokine CX3CL1 in apoptotic and non-apoptotic chondrocytes was assessed with IHC, IF, WB, and ELISA. The function of CX3CL1-CX3CR1 axis in the chemotaxis of OCPs was examined by CX3XR1 inhibitor AZD8797 (AZD) and si-CX3CL1. The regulatory effect of p38 MAPK on CX3CL1 release was verified by p38 inhibitor PH-797804. RESULTS: A temporal and spatial association between cartilage degradation and bone resorption was found in the TMJOA model. The caspase-dependent chondrocyte apoptosis promoted chemotaxis of OCPs, which can be restrained by ZVAD. CX3CL1 was significantly upregulated when chondrocytes underwent apoptosis, and it played a critical role in the recruitment of OCPs, blockage of CX3CL1-CX3CR1 axis resulted in less bone resorption in TMJOA. P38 MAPK was activated in apoptotic chondrocytes, and had a regulatory effect on the synthesis and release of CX3CL1. After inhibition of p38 by PH-797804, the chemotactic effect of apoptotic chondrocytes on OCPs was limited. CONCLUSIONS: This study indicates that apoptosis of chondrocytes in TMJOA enhances chemotaxis of OCPs toward osteoclast precursors through upregulation of the p38-CX3CL1 axis, thereby promoting the activation of local osteoclasts.


Asunto(s)
Resorción Ósea , Cartílago Articular , Osteoartritis , Animales , Apoptosis , Resorción Ósea/metabolismo , Cartílago Articular/metabolismo , Caspasas/metabolismo , Caspasas/farmacología , Quimiotaxis , Condrocitos/metabolismo , Osteoartritis/metabolismo , Osteoclastos , Ratas , Articulación Temporomandibular/metabolismo , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo
2.
Artículo en Zh | MEDLINE | ID: mdl-33781047

RESUMEN

Graphene oxide is a novel two-dimensional carbon nanomaterial, but it has potential risks for the health of occupationally exposed workers. This article briefly reviews the research progress on the cytotoxic mechanism of graphene oxide and its derivatives in terms of oxidative stress, physical damage and dysfunction of enzyme activity. This review also discusses effective measures for the mitigation of cytotoxicity in order to provide helpful evidence for occupational health risk and biological safety assessment of graphene nanomaterials in China.


Asunto(s)
Grafito , Nanoestructuras , China , Grafito/toxicidad , Humanos , Nanoestructuras/toxicidad , Estrés Oxidativo
3.
Artículo en Zh | MEDLINE | ID: mdl-34624942

RESUMEN

Objective: To investigate the effect and mechanism of PPAR-γ agonist Pioglitazone (PGZ) on the proliferation of malignant mesothelioma (MM) cells. Methods: In December 2019, MM cell lines MSTO-211H and NCI-H2452 were incubated with different final concentrations of PGZ (0, 10, 50, 100, 150, and 200 µmol/L) for different periods of time (24 h, 48 h, and 72 h) , and then the cell proliferation level was detected by CCK8 assay. After given various final concentration of PGZ (0, 10, 50, 100, 150, 200 µmol/L) the for 72 hours, the changes of number and morphology of MM cells were observed under an inverted microscope. The expressions of PPAR-γ and HMGB1 mRNA were determined by real-time fluorescence quantitative reverse transcription-polymerase chain reaction (qRT-PCR) after treatment of MM cells with PGZ of 0, 10, 50, 100 µmol/L for 72 h. The MM cells were treated with PGZ at concentration of 0, 100 µmol/L for 72 h, and the protein expressions of HMGB1 were examined using Western blotting and immunofluorescence; the protein expressions of Ki67 were assessed by immunohistochemistry. Results: The cell viability rate of MM cells was decreased after treated with PGZ (P<0.05) . Cell number in PGZ-treated group was significantly less than that in control group and morphology changes were observed under light microscope. QRT-PCR results revealed significantly increased PPAR-γ mRNA expression in the PGZ-treated group compared to the control group (P<0.05) . There was a significant decrease in the mRNA expression level of HMGB1 in the PGZ-treated group (100 µmol/L) as compared to the control group in MSTO-211H (P<0.05) ; however, the expression level of HMGB1 in NCI-H2452 was an increase or no significant differences (P>0.05) . Western blotting and immunofluorescence results showed that the protein expression of HMGB1 was reduced in the PGZ-treated group compared with the control group in MSTO-211H (P<0.05) , but the protein expression of that in NCI-H2452 was no significant differences (P>0.05) . Immunohistochemistry results showed increased expression of proliferation marker Ki-67. Conclusion: Pioglitazone suppresses the proliferation of MM cells through inhibition of HMGB1 by the activation of PPAR-γ.


Asunto(s)
Proteína HMGB1 , Mesotelioma/tratamiento farmacológico , PPAR gamma/agonistas , Pioglitazona/farmacología , Recuento de Células , Línea Celular Tumoral , Proliferación Celular , Humanos
4.
Beijing Da Xue Xue Bao Yi Xue Ban ; 50(2): 279-283, 2018 Apr 18.
Artículo en Zh | MEDLINE | ID: mdl-29643527

RESUMEN

OBJECTIVE: To investigate the association between single nucleotide polymorphisms (SNP) of ADAMTS14 gene rs4747096 and osteoarthritis of the temporomandibular joint in Chinese Han females. METHODS: As a case-control study, a total of 213 Chinese Han females were involved in the present study, which contained 103 temporomandibular joint osteoarthritis patients and 110 healthy people who had no symptoms or signs of temporomandibular joint osteoarthritis as control. Peripheral blood samples were collected from each participant. Genomic DNAs of temporomandibular joint osteoarthritis patients and healthy control were extracted from peripheral venous blood, which were stored in -80 °C refrigerator by using DNA extraction kits. The designed primers were used for polymerase chain reaction (PCR) amplification of specific DNA fragments. Genotype was determined by sequencing the PCR products. The software Chromas 2.22 was used to analyze the genotype. The genotype distributions, allele frequencies and genetic models between the patients and controls were compared. The age distribution was checked by t-test. Genotype and allele frequency were detected by Chi-square test. RESULTS: In the present study, there were no significant differences between the osteoarthritis patients and healthy controls in terms of age. The genotype distribution was in accordance with Hardy-Weinberg equilibrium in the two groups. The genotype frequency of the ADAMTS14 (rs4747096) in the experimental group was 38.8% (AA), 55.4% (AG), and 5.8% (GG), respectively. The genotype frequency in the control group was 40.9% (AA), 43.6% (AG), and 15.5% (GG), respectively. The difference of genotype frequency of the ADAMTS14 (rs4747096) was significant between the experimental group and the control group (P=0.047). There was no significant difference in allele frequency between the two groups (P=0.415). AA and AG genotypes significantly increased the risk of the disease compared with GG in dominant model (OR=1.114, 95% CI: 1.015-1.223, P=0.028). CONCLUSION: A significant correlationship was found between the ADAMTS14 (rs4747096) SNP and the temporomandibular joint osteoarthritis in Chinese Han females. The distribution of rs4747096 may be different between temporomandibular joint osteoarthritis and healthy population.


Asunto(s)
Proteínas ADAMTS/genética , Predisposición Genética a la Enfermedad , Osteoartritis/genética , Polimorfismo de Nucleótido Simple , Articulación Temporomandibular/patología , Pueblo Asiatico , Estudios de Casos y Controles , Femenino , Frecuencia de los Genes , Genotipo , Humanos , Osteoartritis/etnología , Reacción en Cadena de la Polimerasa
5.
Oral Dis ; 23(3): 353-359, 2017 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-27917567

RESUMEN

OBJECTIVE: The aim of this study was to investigate the effects of rinsing with arginine or urea solution on initial enamel lesions in situ. METHODS: Fourteen subjects who wore mandibular removable partial dentures embedded with bovine enamel blocks with artificial enamel lesions were included. The experiment included four 4-week rinsing periods with a 10-day washout period between each rinsing period. In each rinsing period, the subjects rinsed after meal or snack using water, or 2% arginine bicarbonate, or 1% urea, or 0.05% NaF solution, five times daily. The mineralization changes of the enamel lesions were assessed using quantitative light-induced fluorescence. RESULTS: All groups except the water group showed a statistically significant decrease in the fluorescence loss after treatment, compared with their respective baseline. Although both the arginine group and urea group showed more decrease in fluorescence loss than that of the water group, the decrease was not statistically significantly different from that of the water group. The decrease in fluorescence loss of the NaF group was statistically significant than that of the water group, arginine group, and urea group. CONCLUSION: Rinsing with arginine or urea solution offers limited remineralizing benefit to enamel lesions over a period of 4-week time.


Asunto(s)
Arginina/análogos & derivados , Arginina/farmacología , Carbonatos/farmacología , Cariostáticos/farmacología , Esmalte Dental/efectos de los fármacos , Remineralización Dental , Urea/farmacología , Adulto , Anciano , Estudios Cruzados , Caries Dental/prevención & control , Esmalte Dental/patología , Método Doble Ciego , Femenino , Humanos , Masculino , Persona de Mediana Edad , Antisépticos Bucales/farmacología , Fluoruro de Sodio/farmacología , Agua/farmacología
6.
J Oral Rehabil ; 42(7): 529-36, 2015 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-25757091

RESUMEN

Temporomandibular joint osteoarthritis (TMJOA) is a complex disease and has a strong genetic component in its pathogenesis. Experimental evidence suggests the involvement of biological pathway in the disease. This case-control study was designed to investigate whether five common single nucleotide polymorphisms (SNPs) in GDF5, SMAD3, RUNX2, TGFß1 and CHST11, respectively, are associated with TMJOA in female Han Chinese patients. A total of 240 participants were evaluated comprising 114 female patients diagnosed with TMJOA based on Research Diagnostic Criteria for Temporomandibular Disorders and 126 healthy female controls. The SNPs of the five genes in the genomic DNA were examined by sequencing, and their allelic, genotypic and carriage rate frequency distributions, as well as the triple combination of the risk genotypes, were analysed using the logistic regression model. The SNP in GDF5 or SMAD3 showed significant association with TMJOA, a relatively weak association was observed in RUNX2. In the triple combinational analysis, the risk of TMJOA grew 5·09 times in the patients with five or six risk alleles (P < 0·01). This is the first study to evaluate the association of GDF5, SMAD3, RUNX2, TGFß1 and CHST11 with TMJOA in female Han Chinese. Our study suggests that the SNPs of genes related to TGFß family might contribute to the risk of TMJOA.


Asunto(s)
Subunidad alfa 1 del Factor de Unión al Sitio Principal/genética , Factor 5 de Diferenciación de Crecimiento/genética , Osteoartritis/genética , Polimorfismo de Nucleótido Simple/genética , Proteína smad3/genética , Trastornos de la Articulación Temporomandibular/genética , Adolescente , Adulto , Pueblo Asiatico/genética , Estudios de Casos y Controles , Niño , Femenino , Predisposición Genética a la Enfermedad , Humanos , Modelos Logísticos , Persona de Mediana Edad , Sulfotransferasas/genética , Factor de Crecimiento Transformador beta1/genética , Adulto Joven
7.
Clin Radiol ; 69(11): 1129-35, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-25060936

RESUMEN

AIM: To evaluate whether contrast-enhanced ultrasound (CEUS)-guided radiofrequency ablation (RFA) can be performed effectively in small hepatic malignancies that are invisible or poorly visualized at traditional grey-scale ultrasonography (US). MATERIALS AND METHODS: The institutional ethics committee approved the study, and all patients provided written informed consent before their enrolment. The study focused on 55 patients (43 men, 12 women, age 57.4 ± 10.9 years) with 60 hepatic lesions from May 2010 to March 2011. All lesions were treated with multipolar radiofrequency ablation (RFA). During the RFA procedure, with the injection of ultrasound contrast agent (sulphur hexafluoride; SonoVue, Bracco Imaging Spa, Milan, Italy), RFA was conducted under CEUS guidance when the optimal depiction of a lesion was obtained. Artificial pleural effusions were used in those cases obstructed by the lungs. Twenty-four hours after RFA, contrast-enhanced MRI was used as the reference standard to evaluate the primary effectiveness rate and complete tumour necrosis. The follow-up time was 12-24 months (median 15 months). RESULTS: Among 60 hepatic malignancies, CEUS detected 57 lesions (95%), which was higher than that at US (26.6%). Artificial pleural effusions were performed in three cases, resulting in the detection of three additional lesions. The insertion of RFA electrodes was monitored by CEUS in all lesions. Immediately after RFA, complete tumour necrosis were achieved in all 60 lesions as apparent at MRI, for a primary effectiveness rate of 100%. CONCLUSION: CEUS-guided RFA is a promising technique for targeting and improving the efficiency of treatment of hepatic malignancies.


Asunto(s)
Ablación por Catéter/métodos , Neoplasias Hepáticas/diagnóstico por imagen , Neoplasias Hepáticas/cirugía , Ultrasonografía Intervencional , Medios de Contraste , Femenino , Gadolinio DTPA , Humanos , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Fosfolípidos , Ondas de Radio , Hexafluoruro de Azufre , Resultado del Tratamiento
8.
J Dent Res ; 99(4): 446-455, 2020 04.
Artículo en Inglés | MEDLINE | ID: mdl-31977264

RESUMEN

Severe inflammation, progressive cartilage, and bone destruction are typical pathologic changes in temporomandibular joint (TMJ) arthritis and lead to great difficulty for treatment. However, current therapy is inefficient to improve degenerative changes in progressive TMJ arthritis. This study investigated the therapeutic effects of human dental pulp stem cells (DPSCs) on severe inflammatory TMJ diseases. Progressive TMJ arthritis in rats was induced by intra-articular injection of complete Freund's adjuvant and monosodium iodoacetate. DPSCs were injected into the articular cavity to treat rat TMJ arthritis, with normal saline injection as control. Measurement of head withdrawal threshold, micro-computed tomography scanning, and histologic staining were applied to evaluate the severity of TMJ arthritis. Results showed that local injection of DPSCs in rats with TMJ arthritis relieved hyperalgesia and synovial inflammation, attenuated cartilage matrix degradation, and induced bone regeneration. Inflammatory factors TNF-α and IFN-γ were elevated in progressive TMJ arthritis and partially decreased by local injection of DPSCs. MMP3 and MMP13 were elevated in the arthritis + normal saline group and decreased in the arthritis + DPSCs group, which indicated amelioration of matrix degradation. The isolated primary synoviocytes were cocultured with DPSCs after inflammatory factors stimulated to explore the possible biological mechanisms. The expression of MMP3 and MMP13 in synoviocytes was elevated after TNF-α and IFN-γ stimulation and partially reversed by DPSC treatment in the in vitro study. The signal transducer and activator of transcription 1 (STAT1) was activated by inflammatory stimulation and suppressed by DPSC coculture. The upregulation of MMP3 and MMP13 triggered by inflammation was blocked by STAT1-specific inhibitor, suggesting that STAT1 regulated the expression of MMP3 and MMP13. In conclusion, this study demonstrated the possible therapeutic effects of local injection of DPSCs on progressive TMJ arthritis by inhibiting the expression of MMP3 and MMP13 through the STAT1 pathway.


Asunto(s)
Artritis Experimental , Trastornos de la Articulación Temporomandibular , Animales , Artritis Experimental/tratamiento farmacológico , Adyuvante de Freund , Humanos , Ratas , Factor de Transcripción STAT1 , Transducción de Señal , Articulación Temporomandibular , Trastornos de la Articulación Temporomandibular/tratamiento farmacológico , Microtomografía por Rayos X
9.
J Dent Res ; 96(5): 586-594, 2017 May.
Artículo en Inglés | MEDLINE | ID: mdl-28060561

RESUMEN

Immunologic response plays an important role in orthodontic tooth movement (OTM) and relapse. Nonsteroidal anti-inflammatory drugs, such as aspirin, affect immune cells and clinical orthodontic treatment. However, the mechanisms by which nonsteroidal anti-inflammatory drugs regulate immune cells to affect orthodontic relapse are unclear. In this study, male Sprague-Dawley rats were grouped as relapse and relapse + aspirin for 10 d after 14 d of OTM. Silicone impressions of the rats' maxillary dentitions were obtained to record the distance of OTM at the indicated time point. CD4+ T lymphocytes in spleen were examined by flow cytometry. Serum levels of type 1 T-helper (Th1) cell-associated cytokines tumor necrosis factor α (TNF-α), and interferon γ (IFN-γ) were determined through enzyme-linked immunosorbent assay. The effects of aspirin on CD4+ T and Th1 cells were also analyzed in vitro. Aspirin treatment significantly reduced the relapse rate. More interestingly, injection of CD25 neutralizing antibody basiliximab or TNF-α inhibitor etanercept can significantly reduce the relapse rate as well. Correspondingly, aspirin treatment significantly accelerated the decrease of orthodontic force-induced secretion of TNF-α and IFN-γ in serum and the expression of TNF-α and IFN-γ in periodontal ligament during relapse. Furthermore, aspirin treatment in vitro significantly repressed the differentiation of CD4+ T and Th1 cells. Overall, results indicated that aspirin treatment can block orthodontic relapse by regulating Th1 cells.


Asunto(s)
Aspirina/farmacología , Linfocitos T CD4-Positivos/inmunología , Células TH1/inmunología , Técnicas de Movimiento Dental , Animales , Ensayo de Inmunoadsorción Enzimática , Citometría de Flujo , Interferón gamma/metabolismo , Masculino , Maxilar/diagnóstico por imagen , Osteoclastos/inmunología , Ratas , Ratas Sprague-Dawley , Recurrencia , Bazo/citología , Factor de Necrosis Tumoral alfa/metabolismo , Microtomografía por Rayos X
10.
Oncogene ; 35(18): 2333-44, 2016 05 05.
Artículo en Inglés | MEDLINE | ID: mdl-26279303

RESUMEN

Phosphatase and tensin homologue deleted on chromosome 10 (PTEN), an important tumour-suppressor gene, is mutated, downregulated or dysfunctional in many tumours. The phosphatase activity of PTEN depends on membrane translocation (activation). As promising anti-cancer agents, histone deacetylase (HDAC) inhibitors, particularly trichostatin A (TSA), can promote PTEN membrane translocation, but the underlying mechanism remains unknown. In this study, we revealed that non-selective HDAC inhibitors, namely, TSA or suberoylanilide hydroxamic acid (SAHA), induced PTEN membrane translocation through PTEN acetylation at K163 by inhibiting HDAC6. K163 acetylation inhibited the interaction of the PTEN C-tail with the remaining part of PTEN, resulting in PTEN membrane translocation. Overexpression of wild-type PTEN, but not K163-mutated PTEN, facilitated the inhibition of cell proliferation, migration and invasion, as well as xenograft tumour growth, induced by SAHA or tubastatin A, an HDAC6-specific inhibitor. These results indicated that PTEN activation by inhibiting HDAC6 significantly contributed to tumour inhibition. Therefore, non-selective HDAC or HDAC6-specific inhibitors may be more clinically suitable to treat tumours without PTEN mutations or deletions.


Asunto(s)
Inhibidores de Histona Desacetilasas/farmacología , Histona Desacetilasas/metabolismo , Lisina/metabolismo , Fosfohidrolasa PTEN/metabolismo , Acetilación/efectos de los fármacos , Animales , Línea Celular Tumoral , Membrana Celular/efectos de los fármacos , Membrana Celular/metabolismo , Movimiento Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Activación Enzimática/efectos de los fármacos , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Histona Desacetilasa 6 , Humanos , Ácidos Hidroxámicos/farmacología , Ratones , Invasividad Neoplásica , Transporte de Proteínas/efectos de los fármacos , Vorinostat , Ensayos Antitumor por Modelo de Xenoinjerto
11.
Eur J Pain ; 20(3): 353-64, 2016 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-26014463

RESUMEN

BACKGROUND: Patients with an orofacial pain history appear to be more susceptible to occlusal interference pain in dental practice for unknown reasons. Pain memory has a critical function in subsequent pain perception. This study aims to explore whether orofacial pain memory could affect the masticatory muscle pain perception for occlusal interference. METHODS: Cross-injection of 2% carrageenan into bilateral masseters in male rats was carried out to establish the inflammatory pain memory model. The effects of pain memory on masseter muscle nociception were tested by applying crowns with heights beyond the occlusal plane by 0.2 or 0.4 mm onto a maxillary molar 2 weeks after inflammation in the right masseter. The 0.4-mm crowns were removed on day 2 or day 4 after application to further confirm the effects of pain memory. Moreover, memory impairment was established using ibotenic acid (IBO) infusion into the bilateral hippocampus, followed by behaviour tests, including the Morris water maze test and the locomotor activity test. The relationship between pain memory and occlusal interference-induced masseter muscle pain perception was subsequently re-examined. The head withdrawal thresholds of masseters on both sides were measured to reflect the perception. RESULTS: Inflammatory pain memory aggravated the 0.2-mm crown-induced mechanical hyperalgesia of the masseters, but not in the 0.4-mm crown group. However, the recovery of the 0.4-mm crown-induced mechanical hyperalgesia was postponed. The effects of pain memory were reversed in rats with impaired mnemonic function of the hippocampus. CONCLUSIONS: Inflammatory pain memory facilitated occlusal interference-induced masseter muscle pain.


Asunto(s)
Dolor Facial/etiología , Dolor Facial/psicología , Hiperalgesia/etiología , Hiperalgesia/psicología , Inflamación/complicaciones , Inflamación/psicología , Músculos Masticadores/fisiopatología , Memoria , Animales , Carragenina , Ácido Iboténico , Masculino , Aprendizaje por Laberinto , Trastornos de la Memoria/inducido químicamente , Trastornos de la Memoria/psicología , Actividad Motora , Nocicepción , Percepción del Dolor , Umbral del Dolor , Ratas , Ratas Sprague-Dawley
12.
J Dent Res ; 95(10): 1169-75, 2016 09.
Artículo en Inglés | MEDLINE | ID: mdl-27418173

RESUMEN

The exact mechanism underlying chronic masticatory myalgia (CMM), a conspicuous symptom in temporomandibular disorders, remains unclear. This investigation compared gene expression profiles between CMM patients and healthy subjects. Peripheral blood leukocytes were collected in 8 cases and 8 controls and subjected to whole genome microarray analyses. Data were analyzed with Gene Ontology and interactive pathways analyses. According to Gene Ontology analysis, categories such as ion transport, response to stimuli, and metabolic process were upregulated. The pathway analysis suggested overexpression of the mitogen-activated protein kinase (MAPK) pathway in CMM patients and to a higher degree in a pathway network. Overexpression of representative members of the MAPK pathway-including MAPK kinase 3 (MEK3), calcium voltage-gated channel auxiliary subunit gamma 2 (CACNG2), and growth arrest and DNA damage-inducible gamma (GADD45G)-was validated with real-time polymerase chain reaction. The upregulation of MEK3 was negatively correlated with the age of the CMM group. In the next step, the authors focused on MEK3, the gene that exhibited the greatest degree of differential expression, and its downstream target protein p38 MAPK. The results revealed upregulation of MEK3, as well as phosphorylated MEK3 and phosphorylated p38 MAPK, in CMM patients. These results provide a "fingerprint" for mechanistic studies of CMM in the future and highlight the importance of MEK3-p38 MAPK activation in CMM.


Asunto(s)
Canales de Calcio/genética , Regulación Enzimológica de la Expresión Génica , Péptidos y Proteínas de Señalización Intracelular/genética , MAP Quinasa Quinasa 3/genética , Proteínas Quinasas Activadas por Mitógenos/genética , Mialgia/genética , Sistema Estomatognático/metabolismo , Trastornos de la Articulación Temporomandibular/genética , Adolescente , Adulto , Anciano , Western Blotting , Canales de Calcio/metabolismo , Dolor Crónico/genética , Dolor Crónico/metabolismo , Femenino , Humanos , Péptidos y Proteínas de Señalización Intracelular/metabolismo , MAP Quinasa Quinasa 3/metabolismo , Masculino , Análisis por Micromatrices , Persona de Mediana Edad , Proteínas Quinasas Activadas por Mitógenos/metabolismo , Mialgia/metabolismo , Fosforilación , Reacción en Cadena en Tiempo Real de la Polimerasa , Trastornos de la Articulación Temporomandibular/metabolismo , Regulación hacia Arriba , Proteínas Quinasas p38 Activadas por Mitógenos/genética , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo
13.
J Dent Res ; 94(10): 1392-400, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26250572

RESUMEN

Ankylosed bone mass in temporomandibular joint ankylosis (TMJA) is an important factor affecting mouth-opening limitation. However, the mechanism underlying the occurrence of ankylosed bone mass remains unknown. Research has shown that osteoblasts and osteoclasts maintain balance in bone remodeling. Thus, we hypothesized that aberrant osteoclastogenesis and osteogenesis may be involved in the occurrence of ankylosed bone mass in TMJA. In this study, we characterized the osteogenesis of bone marrow stem cells and the osteoclastogenesis of myelomonocyte in clinical specimens of TMJA and normal controls. Results showed that, compared with control bone marrow stem cells, TMJA bone marrow stem cells had lower proliferative and osteogenic capacities. The number of osteoclasts in the ankylosed bone mass group dramatically decreased, and myelomonocyte osteoclastogenic potential was impaired. The RANKL/OPG ratio of the ankylosed bone mass group was lower than that of the control group. Thus, our study suggests that osteoclast deficiency may be an important factor affecting bone mass ankylosis.


Asunto(s)
Anquilosis/etiología , Osteoclastos/fisiología , Trastornos de la Articulación Temporomandibular/etiología , Anquilosis/diagnóstico por imagen , Densidad Ósea , Humanos , Osteogénesis/fisiología , Articulación Temporomandibular/diagnóstico por imagen , Articulación Temporomandibular/fisiopatología , Trastornos de la Articulación Temporomandibular/diagnóstico por imagen , Tomografía Computarizada por Rayos X
14.
J Dent Res ; 94(5): 666-73, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25744069

RESUMEN

Osteoarthritis is a common disease that can cause severe pain and dysfunction in any joint, including the temporomandibular joint (TMJ). TMJ osteoarthritis (TMJOA) is an important subtype in the classification of temporomandibular disorders. TMJOA pathology is characterized by progressive cartilage degradation, subchondral bone remodeling, and chronic inflammation in the synovial tissue. However, the exact pathogenesis and process of TMJOA remain to be understood. An increasing number of studies have recently focused on inflammation and remodeling of subchondral bone during the early stage of TMJOA, which may elucidate the possible mechanism of initiation and progression of TMJOA. The treatment strategy for TMJOA aims at relieving pain, preventing the progression of cartilage and subchondral bone destruction, and restoring joint function. Conservative therapy with nonsteroidal anti-inflammatory drugs, splint, and physical therapy, such as low-energy laser and arthrocentesis, are the most common treatments for TMJOA. These therapies are effective in most cases in relieving the signs and symptoms, but their long-term therapeutic effect on the pathologic articular structure is unsatisfactory. A treatment that can reverse the damage of TMJOA remains unavailable to date. Treatments that prevent the progression of cartilage degradation and subchondral bone damage should be explored, and regeneration for the TMJ may provide the ideal long-term solution. This review summarizes the current understanding of mechanisms underlying the pathogenesis and treatment of TMJOA.


Asunto(s)
Osteoartritis/etiología , Trastornos de la Articulación Temporomandibular/etiología , Regeneración Ósea/fisiología , Remodelación Ósea/fisiología , Cartílago Articular/fisiopatología , Progresión de la Enfermedad , Humanos , Osteoartritis/terapia , Sinovitis/etiología , Trastornos de la Articulación Temporomandibular/terapia , Ingeniería de Tejidos/métodos
15.
Eur J Cancer ; 35(7): 1123-9, 1999 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-10533458

RESUMEN

Intravesical Bacillus Calmette-Guerin (BCG) immunotherapy is currently the optimal choice for aggressive superficial bladder cancer, with a 70% response rate. This study investigated whether the antitumour response elicited by BCG could be improved by the addition of recombinant interferon alpha (IFN alpha) in the subcutaneous murine MB49 bladder tumour model. The combination of BCG and IFN alpha had superior and earlier antitumour activity than BCG alone for MB49 cells in culture. A total of 14/15 BCG plus interferon-treated mice and 8/16 BCG-treated mice became tumour free after treatment. BCG or the combination treatment significantly raised the T-helper 1 (Th1) cytokine IFN gamma levels compared with levels in all other groups. Whilst BCG therapy alone increased CD4+ and CD8+ populations in spleens, the combination of BCG and IFN alpha also increased alpha beta+ T cells significantly. Our results suggest that the combination of BCG and IFN alpha may represent a more efficacious therapeutic than BCG alone for superficial bladder cancer.


Asunto(s)
Antineoplásicos/uso terapéutico , Vacuna BCG/uso terapéutico , Interferón-alfa/uso terapéutico , Neoplasias de la Vejiga Urinaria/terapia , Animales , Antineoplásicos/inmunología , Vacuna BCG/inmunología , División Celular , Femenino , Factores Inmunológicos/inmunología , Factores Inmunológicos/uso terapéutico , Inmunoterapia , Interferón-alfa/inmunología , Ratones , Ratones Endogámicos C57BL , Neoplasias de la Vejiga Urinaria/inmunología , Neoplasias de la Vejiga Urinaria/patología
16.
Immunol Lett ; 49(3): 191-6, 1996 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-8739316

RESUMEN

The mechanisms of cytotoxic killing of various tumor cell lines and immunodeficiency virus-infected T cell lines by simian gamma delta T cells were examined. The lysis of the majority of the target cell lines by gamma delta effectors was calcium-dependent, indicating that cytotoxicity is mediated by the perforin/granzyme pathway rather than the Fas-FasL pathway, with the exception of Jurkat cells. The gamma delta T cells were able to suppress SIV replication as measured by the p27 ELISA and the suppression was contact-dependent. We further determined that the target cells were induced to undergo apoptosis by the gamma delta T cell effectors. These results contribute to our understanding of the function of simian gamma delta T cells and their similarities to human gamma delta T cells, and extend our knowledge on the cytotoxic mechanisms employed by gamma delta T cells in general.


Asunto(s)
Receptores de Antígenos de Linfocitos T gamma-delta/inmunología , Síndrome de Inmunodeficiencia Adquirida del Simio/inmunología , Virus de la Inmunodeficiencia de los Simios/inmunología , Subgrupos de Linfocitos T/inmunología , Animales , Antígenos CD19/inmunología , Apoptosis , Calcio/fisiología , Citotoxicidad Inmunológica , Humanos , Inmunidad Celular , Macaca mulatta , Células Tumorales Cultivadas/inmunología
17.
Immunobiology ; 203(5): 786-99, 2001 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11563678

RESUMEN

In recent years, heat shock proteins have been shown to be effective in enhancing the immunogenicity of tumors. In this study, we examined the effect of mycobacterial hsp65 gene transfection in a non-immunogenic and aggressive tumor cell-line in order to understand the factors that could contribute to the increase in immunogenicity mediated by Hsp65. The transfected cells were found to have indeed lost their tumorigenenicity and increased their immunogenicity. Tumor-specific cytotoxic T cells were present only in mice immunized with the Hsp65-expressing cells. Furthermore, endogenous Hsp70 was significantly increased in irradiated Hsp65-expressing cells and recombinant Hsp65 protein was able to stimulate the mRNA expression of various T helper 1 (Th1) and pro-inflammatory cytokines in splenocyte cultures, as well as a modest expansion of CD4 T cells. These results provide further evidence of the immunomodulating properties of Hsp65, which could be exploited for the treatment of cancer.


Asunto(s)
Adyuvantes Inmunológicos/farmacología , Proteínas Bacterianas , Chaperoninas/fisiología , Neoplasias Experimentales/inmunología , Animales , Chaperonina 60 , Chaperoninas/metabolismo , Citocinas/metabolismo , Femenino , Proteínas HSP70 de Choque Térmico/metabolismo , Subgrupos Linfocitarios/inmunología , Ratones , Ratones Endogámicos C57BL , Ratones SCID , Trasplante de Neoplasias , Linfocitos T Citotóxicos/inmunología , Transfección , Células Tumorales Cultivadas
18.
Neurol Res ; 19(3): 261-4, 1997 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-9192378

RESUMEN

This project was designed to examine the epidemiology of traumatic brain injury (TBI) in Taiwan. A total of 58,563 cases of TBI was collected from 114 hospitals in Taiwan during the period July 1, 1988-June 30, 1994. Traffic accident was the major cause of TBI (69.4%), followed by falls and assaults. Motorcyclists accounted for the vast majority of TBI cases among traffic accident victims (64.5%). The Glasgow Coma Scale was used in assessing the severity. 41,646 cases (79.5%) were considered mild, 4,637 cases (8.9%) moderate, and 6,078 cases (11.6%) severe. Skull x-ray showed fracture in 7,663 cases (14.6%). Intracranial hemorrhage was identified in 28.6% of patients receiving CT scanning. Craniotomy was performed in 5,226 cases (9%). The outcome of TBI was determined by the Glasgow Outcome Scale. Death occurred in 2,621 cases (5.4%), vegetative state in 429 cases (0.9%), severe disability in 1,293 cases (2.6%), moderate disability in 1,890 cases (3.9%), and good recovery in 42,596 cases (87.2%). The severity and outcome were worse than those of Western reports. In order to alleviate this problem, a helmet use persuasion program was conducted by the Police Department in Taipei City from January to June, 1994. Results of this program showed a significant reduction of TBI-related hospitalization, severity and fatality during this period of intervention. This study points out the seriousness of TBI in Taiwan and suggests some approaches and priorities for prevention.


Asunto(s)
Lesiones Encefálicas/epidemiología , Sistema de Registros , Accidentes de Tránsito/estadística & datos numéricos , Adolescente , Adulto , Anciano , Lesiones Encefálicas/terapia , Niño , Preescolar , Escala de Coma de Glasgow , Dispositivos de Protección de la Cabeza/estadística & datos numéricos , Humanos , Lactante , Recién Nacido , Persona de Mediana Edad , Motocicletas/estadística & datos numéricos , Taiwán/epidemiología , Resultado del Tratamiento , Heridas y Lesiones/epidemiología , Heridas y Lesiones/terapia
19.
J Biol Regul Homeost Agents ; 15(3): 277-85, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11693437

RESUMEN

Activated gammadelta T cells undergo apoptosis upon restimulation of their T cell receptor (TCR)/CD3 complex. We demonstrate that in these cells, the activation-induced cell death (AICD) is mediated by Fas and Fas ligand (FasL) interaction. The activated gammadelta T cells are prone to AICD initiated by exposure to mitogens, anti-TCR/CD3 antibodies, as well as specific antigens such as Daudi cells or ethylpyrophosphate (Etpp). Cells that have been activated twice, and consequently more susceptible to AICD than primary cells, display augmented tyrosine phosphorylation in comparison with control cells. These studies outline a mechanism that may regulate gammadelta T cell activities in immune responses and limit the expansion of activated T cells repeatedly exposed to antigens.


Asunto(s)
Apoptosis , Activación de Linfocitos , Receptores de Antígenos de Linfocitos T gamma-delta/análisis , Linfocitos T/fisiología , Receptor fas/fisiología , Calcio/metabolismo , Línea Celular , Ácido Egtácico/farmacología , Humanos , Separación Inmunomagnética , Fosforilación , Tirosina/metabolismo
20.
Chin Med J (Engl) ; 107(4): 289-94, 1994 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-8088198

RESUMEN

In the evaluation of Chinese herbs (A), ear-acupuncture (B) and epidural morphine (C) to relieve postoperative pain and abdominal distension, sixteen male patients with primary liver cancer were observed. This study was conducted by means of orthogonal experiment and double blind, randomized design. The patients received various treatments according to the display of the orthogonal table L16(2)15 which corresponds to 2(3) factorial experiment design. C+ (morphine 2 mg) was given before the peritoneum was sutured. A+ (orally administered) and B+ were given 24 hours after operation. 50-100 mg of pethidine was given when the pain intensity VAS (0-100) exceeded 50-70. The observation parameters included plasma leucine enkephalin (LEK), postoperative total dosage of narcotics administered for 5 days, VAS for pain and pain reliever, abdominal distension, urinary retention, constipation, etc. The results were as follows: a. Patients who had received A (A+B+C+, A+B+C-, A+B-C-, A+B-C+); C (C+A+B+, C+A+B-, C+A-B+, C+A-B-), or B (B+A+C+, B+A+C-, B+A-C+, B+A-C-) produced better analgesic effects than those who had received placebo. The A, B, and C reduced narcotics 650, 450 and 550 mg respectively when compared with placebo. The effects of A and C were of statistical significance (P < 0.05), while AB, BC, and AC interactions were not found; b. A and B minimized abdominal distension and urinary retention, while C prolonged them. As compared with the placebo, A and B accelerated restoration of bowel peristalsis (P < 0.05, ANOVA). Both A and B decreased it for 165 hours, while epidural morphine prolonged it for 49 hours; and c.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Puntos de Acupuntura , Medicamentos Herbarios Chinos/uso terapéutico , Morfina/administración & dosificación , Dolor Postoperatorio/terapia , Adulto , Anciano , Carcinoma Hepatocelular/cirugía , Terapia Combinada , Método Doble Ciego , Oído Externo , Flatulencia/terapia , Humanos , Inyecciones Epidurales , Neoplasias Hepáticas/cirugía , Masculino , Persona de Mediana Edad , Presión
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA